Preetam Shah - 15 Apr 2025 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role: Chief Strategy and Financial Officer
Signature: /s/ Preetam Shah
Issuer symbol: ELTX
Transactions as of: 15 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 16 Apr 2025, 17:12:23 UTC
Previous filing: 02 Apr 2025
Next filing: 03 Feb 2026
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELTX	Stock Option (Right to Buy)	Award	$0	+191,624		$0.000000	191,624	15 Apr 2025	Common Stock	191,624	$4.98	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock option vests and becomes exercisable as to 25% of the options on March 24, 2025, the first anniversary of the Reporting Person's start date, with the remaining options vesting in equal monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Remarks:

Chief Strategy and Financial Officer